Search results for "FUNGAL"

showing 10 items of 1116 documents

Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving or…

2015

Studies that analyze the epidemiology and risk factors for invasive fungal disease (IFD) after engraftment in alloSCT are few in number. This single-center retrospective study included 404 alloSCT adult recipients surviving > 40 days who engrafted and were discharged without prior IFD. All patients who received >= 20 mg/day of prednisone were assigned to primary oral prophylaxis (itraconazole or low-dose voriconazole). The primary end point was the cumulative incidence (CI) of probable/proven IFD using the European Organization for Research and Treatment of Cancer and Mycoses Study Group (EORTC/MSG) criteria. The independent prognostic factors after multivariate analyses were used to constr…

MaleAntifungal AgentsTransplantation ConditioningPremedicationmedicine.medical_treatmentMULTICENTERAdministration OralHematopoietic stem cell transplantationEchinocandinsCOMPETING RISKCaspofunginRisk FactorsCause of DeathINFECTIONGranulocyte Colony-Stimulating FactorEPIDEMIOLOGYCumulative incidenceTreatment FailureFramingham Risk ScoreIncidenceIncidence (epidemiology)Hematopoietic Stem Cell TransplantationHematologyMiddle AgedAllograftsHematologic NeoplasmsVORICONAZOLEDrug Therapy CombinationFemaleASPERGILLOSISRisk assessmentFungemiamedicine.drugAdultmedicine.medical_specialtyNeutropeniaANTIFUNGAL PROPHYLAXISNeutropeniaRisk AssessmentITRACONAZOLEMedication AdherenceImmunocompromised HostLipopeptidesYoung AdultAmphotericin BInternal medicinemedicineAspergillosisHumansAgedRetrospective StudiesVoriconazoleTransplantationbusiness.industryRetrospective cohort studyFLUCONAZOLETriazolesmedicine.diseaseSurvival AnalysisSurgeryMycosesPatient CompliancebusinessSCT
researchProduct

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

2006

Background: Micafungin (FK463) is a new lipopeptide compound (echinocandin) with activity against Aspergillus and Candida species. This study evaluated the safety and efficacy of micafungin in patients with proven or probable invasive aspergillosis (IA). Methods: A multinational, non-comparative study was conducted to examine proven or probable (pulmonary only) Aspergillus species infection in a wide variety of patient populations. The study employed an open-label design utilizing micafungin alone or in combination with another systemic antifungal agent. Criteria for IA and therapeutic responses were judged by an independent panel. Results: Of the 331 patients enrolled, only 225 met diagnos…

MaleAntifungal Agentsmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationAspergillosisGastroenterologyEchinocandinsAmphotericin BChildAged 80 and overResearch Support Non-U.S. Gov'tMiddle AgedLipoproteins [administration & dosage]Infectious DiseasesChild PreschoolAcute DiseaseCombinationDrug Therapy CombinationFemalemedicine.drugAdultMicrobiology (medical)medicine.medical_specialtyAdolescentEchinocandinLipoproteinsBiologyAntifungalPeptides CyclicArticleLipopeptidesPharmacotherapyInternal medicineAmphotericin BmedicineHumansAspergillosisEchinocandinAgedChemotherapyAspergillosis [drug therapy]MicafunginInfantmedicine.diseasebacterial infections and mycosesSurgeryPeptides Cyclic [administration & dosage]MicafunginAntifungal Agents [administration & dosage]
researchProduct

Histopathological analysis of soft tissue changes in gingival biopsied specimen from patients with underlying corona virus disease associated mucormy…

2021

Corona Virus Disease-2019 (COVID-19) is perhaps the disastrous medical emergencies that has ever hit globally with multiple strains. Amongst various sequelae, mucormycosis may be considered as the most debilitating one. Post COVID-19 mucormycosis is formally regarded as corona virus disease associated mucormycosis (CAM). The aim of the current paper is to present twelve cases of CAM with unique clinical presentation with a detailed histopathological correlation of the gingival biopsied material. Twelve cases of CAM were included in the study who presented initially with non-purulent swelling of the gingiva. The clinic-demographic data pertaining to age, gender, location, laterality and pres…

MaleAntifungal AgentspandemicGingivaCOVID-19ComorbidityMiddle Agedmaxillofacial traumacoronavirus infectionsars-cov-2OtorhinolaryngologyspainHumansMucormycosisSurgeryFemaleGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct

Candida arthritis: cellular immune responses of synovial fluid and peripheral blood lymphocytes to Candida albicans.

1991

A case of septic Candida albicans arthritis of the knee in a patient with systemic candidiasis is presented. Systemic and intra-articular cellular immune responses to C albicans and various bacterial antigens were monitored for 15 weeks. It is shown that the candida induced blastogenesis of synovial fluid lymphocytes was much more stimulated than that of peripheral blood lymphocytes, and that the proportion of activated cells expressing HLA class II antigens was markedly increased in the synovial fluid. Strong cellular immune responses to Candida albicans could still be shown many weeks after the synovial fluid aspirates had become sterile. For the first time synovial fluid derived, CD4 pos…

MaleCellular immunityAntigens FungalKnee JointT-LymphocytesImmunologyArthritisGeneral Biochemistry Genetics and Molecular BiologyEpitopesImmune systemRheumatologyAntigenCandida albicansSynovial FluidmedicineImmunology and AllergySynovial fluidHumansCandida albicansArthritis Infectiousbiologybusiness.industryCandidiasisAntibodies MonoclonalMiddle Agedmedicine.diseasebiology.organism_classificationLymphocyte SubsetsImmunologySystemic candidiasisBacterial antigenbusinessCell DivisionResearch Article
researchProduct

Disseminated fusariosis in immunocompromised patients

2011

Immunocompromised patients are at high risk of developing serious disseminated infections by opportunistic fungi (Aspergillus, Candida, and Fusarium spp), which frequently present as cutaneous lesions, sometimes as a first sign. Prolonged and deep neutropenia, immunodepressive treatments (systemic steroids and chemotherapy) and severe T-cell immunodeficiency are the most important risk factors. We report 2 patients with acute lymphoblastic leukemia, who developed multiple tender erythematous skin lesions on their legs and arms during chemotherapy treatment. Skin biopsies for histology and culture studies established the diagnosis of Fusarium infection. They received treatment with systemic …

MaleFusariummedicine.medical_specialtyAntifungal Agentsmedicine.medical_treatmentDermatologyNeutropeniaImmunocompromised HostYoung AdultFatal OutcomeAmphotericin BGranulocyte Colony-Stimulating FactormedicineHumansYoung adultImmunodeficiencyVoriconazoleChemotherapyAspergillusbiologybusiness.industryMortality rateMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaTriazolesmedicine.diseasebiology.organism_classificationDermatologyPyrimidinesFusariosisImmunologyFemaleVoriconazolebusinessmedicine.drugEuropean Journal of Dermatology
researchProduct

Genetic elimination of known pheromones reveals the fundamental chemical bases of mating and isolation in Drosophila

1999

Overexpression of the UAS-tra transgene in Drosophila melanogaster females led to the complete elimination of their cuticular pheromones. According to current models of Drosophila behavior, these flies should induce no courtship. In fact, they are still attractive to conspecific males. Three classes of stimuli are shown to induce courtship, with different effects on male behavior: ( i ) known pheromones produced by control females, ( ii ) stimuli produced by living control and transgenic flies, and ( iii ) as-yet-undetermined pheromones present on both control and transgenic flies. Only the latter class of pheromones are required for mating. They appear to represent a layer of ancestral at…

MaleHot TemperaturePheromones/genetics/*physiologyPheromonesAnimals Genetically ModifiedCourtshipSexual Behavior AnimalAnimal/*physiologyMelanogasterMatingreproductive and urinary physiologymedia_commonGeneticsMultidisciplinarybiologyBiological SciencesDNA-Binding ProteinsDrosophila melanogasterSocial IsolationSex pheromonebehavior and behavior mechanismsDrosophilaFemaleDrosophila melanogasteranimal structuresSaccharomyces cerevisiae ProteinsGenotypeRecombinant Fusion ProteinsRecombinant Fusion Proteins/biosynthesisSexual BehaviorTransgenemedia_common.quotation_subjectGenetically ModifiedCrossesHSP70 Heat-Shock Proteins/biosynthesis/genetics/physiologyFungal ProteinsGeneticSibling speciesAnimalsHSP70 Heat-Shock ProteinsDrosophilaCrosses Geneticfungibiology.organism_classificationHeatTranscription Factors/biosynthesis/geneticsFungal Proteins/biosynthesis/geneticsHydrocarbonsDrosophila melanogaster/genetics/*physiologyEvolutionary biologyDrosophila/genetics/*physiologyTranscription FactorsProceedings of the National Academy of Sciences
researchProduct

CANDIDA ALBICANS INDUCES SELECTIVE DEVELOPMENT OF MACROPHAGES AND MONOCYTE DERIVED DENDRITIC CELLS BY A TLR2 DEPENDENT SIGNALLING

2011

As TLRs are expressed by haematopoietic stem and progenitor cells (HSPCs), these receptors may play a role in haematopoiesis in response to pathogens during infection. We have previously demonstrated that in in vitro defined conditions inactivated yeasts and hyphae of Candida albicans induce HSPCs proliferation and differentiation towards the myeloid lineage by a TLR2/MyD88 dependent pathway. In this work, we showed that C. albicans invasive infection with a low virulence strain results in a rapid expansion of HSPCs (identified as LKS cells: Lin(-) c-Kit(+) Sca-1(+) IL-7R alpha(-)), that reach the maximum at day 3 post-infection. This in vivo expansion of LKS cells in TLR2(-/-) mice was del…

MaleImmune CellsCellular differentiationImmunologylcsh:MedicineMycologyMicrobiologyMonocytesMiceCandida albicansAnimalsLymphopoiesisProgenitor celllcsh:ScienceCandida albicansBiologyImmune ResponseCells CulturedMice KnockoutMultidisciplinarybiologyMacrophageslcsh:RFungal DiseasesCandidiasisCell DifferentiationHematologyDendritic CellsFlow Cytometrybiology.organism_classificationToll-Like Receptor 2Corpus albicansHematopoiesisCell biologyHost-Pathogen InteractionToll-Like Receptor 4HaematopoiesisTLR2Infectious DiseasesMyeloid Differentiation Factor 88Medicinelcsh:QFemaleStem cellInfectious Disease ModelingResearch ArticleSignal Transduction
researchProduct

Genetic identification of neurons controlling a sexually dimorphic behaviour

2000

0960-9822 (Print) Journal Article Research Support, Non-U.S. Gov't; In the fruit fly Drosophila melanogaster, locomotor activity is sexually dimorphic: female flies constantly modulate their activity pattern whereas males show a steadier, stereotyped walking pace [1]. Here, we mapped the area of the brain controlling this behavioural dimorphism. Adult male Drosophila expressing a dominant feminising transgene in a small cluster of neurons in the pars intercerebralis exhibited a female-like pattern of locomotor activity. Genetic ablation of these neurons prevented the feminisation of the locomotor activity of transgenic males. The results suggest that this cluster of neurons modulates sex-sp…

MaleMESH: NeuronsCourtshipAnimals Genetically ModifiedSexual Behavior Animal0302 clinical medicineMESH: Saccharomyces cerevisiae ProteinsDrosophila ProteinsNervous System Physiological PhenomenaMESH: AnimalsMESH: Sexual Behavior AnimalDrosophila melanogaster/*physiologymedia_commonNeurons0303 health sciencesFungal proteinSex CharacteristicsbiologyAgricultural and Biological Sciences(all)Nuclear ProteinsAnatomyMESH: Transcription FactorsMotor Activity/*physiologyMESH: Motor ActivityDNA-Binding ProteinsFungal Proteins/geneticsNuclear Proteins/*genetics/physiologyDrosophila melanogasterMESH: Fungal Proteins[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]FemaleDrosophila melanogasterGeneral Agricultural and Biological SciencesLocomotionSex characteristicsMESH: Sex CharacteristicsNervous System PhysiologySaccharomyces cerevisiae ProteinsTransgenemedia_common.quotation_subjectRecombinant Fusion ProteinsRecombinant Fusion Proteins/biosynthesisSexual BehaviorMESH: LocomotionTranscription Factors/geneticsGenetically ModifiedMotor ActivityGeneral Biochemistry Genetics and Molecular BiologyMESH: Drosophila melanogasterFungal ProteinsMESH: Animals Genetically Modified03 medical and health sciencesMESH: Recombinant Fusion ProteinsAnimalsDrosophila030304 developmental biologyBiochemistry Genetics and Molecular Biology(all)Animalfungibiology.organism_classificationMESH: MaleSexual dimorphismMale courtship behaviourMESH: Nervous System PhysiologyNeuroscienceMESH: FemaleMESH: Nuclear ProteinsNeurons/*physiology030217 neurology & neurosurgeryTranscription Factors
researchProduct

GM-CSF Programs Hematopoietic Stem and Progenitor Cells During Candida albicans Vaccination for Protection Against Reinfection

2021

More mechanistic studies are needed to reveal the hidden details of in vivo-induced trained immunity. Here, using a Candida albicans live vaccine mouse model we show that vaccination protects mice against a secondary infection and increases the number of bone marrow, and especially, splenic trained monocytes. Moreover, vaccination expands and reprograms hematopoietic stem and progenitor cells (HSPCs) early during infection and mobilize them transiently to the spleen to produce trained macrophages. Trained HSPCs are not only primed for myeloid cell production but also reprogramed to produce a greater amount of proinflammatory cytokines in response to a second challenge. Additionally, their a…

MaleMacrophagesImmunologyVaccinationHSPCsGranulocyte-Macrophage Colony-Stimulating FactorGM-CSFmyelopoiesisRC581-607Hematopoietic Stem CellscandidiasisMice Inbred C57BLMicetrained immunityReinfectionCandida albicansImmunology and AllergyAnimalsCytokinesFemaleFungal VaccinesImmunologic diseases. AllergyOriginal ResearchFrontiers in Immunology
researchProduct

Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats

2007

Objectives: Invasive pulmonary aspergillosis is associated with high mortality. To assess new antifungal therapy options, animal models have to be developed to assess, in an appropriate setting, the activity of new drugs. Methods: Male albino CD rats (125–150 g) were fed with a protein-free diet and received dexamethasone thrice weekly subcutaneously during the whole experiment. After 2 weeks, an inoculum of 10 6 conidia of Aspergillus fumigatus (H11-20) was injected intratracheally. Antifungal treatment was initiated and continued for a total of 7 days. Animals were grouped in numbers of 10. One group of animals served as untreated control, whereas the others were treated with amphotericin…

MaleMicrobiology (medical)medicine.medical_specialtyPosaconazoleAntifungal AgentsDosemedicine.drug_classMicrobial Sensitivity TestsBiologyAspergillosisGastroenterologyDexamethasoneAspergillus fumigatusRats Sprague-DawleyImmunocompromised HostDrug Resistance FungalAmphotericin BAmphotericin BInternal medicinemedicineAnimalsPharmacology (medical)DexamethasoneMycosisPharmacologyDose-Response Relationship DrugAspergillus fumigatusAspergillosis Allergic BronchopulmonaryTriazolesbiology.organism_classificationmedicine.diseaseRatsInfectious DiseasesImmunologyCorticosteroidDrug Therapy Combinationmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct